Chemotherapy and immune checkpoint inhibitor combination, a new standard in squamous non-small cell lung cancer?

Detalles Bibliográficos
Autores principales: Travert, Camille, Tomasini, Pascale, Barlesi, Fabrice
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Editorial Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7225151/
https://www.ncbi.nlm.nih.gov/pubmed/32420082
http://dx.doi.org/10.21037/tlcr.2020.02.08
_version_ 1783534028884803584
author Travert, Camille
Tomasini, Pascale
Barlesi, Fabrice
author_facet Travert, Camille
Tomasini, Pascale
Barlesi, Fabrice
author_sort Travert, Camille
collection PubMed
description
format Online
Article
Text
id pubmed-7225151
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-72251512020-05-15 Chemotherapy and immune checkpoint inhibitor combination, a new standard in squamous non-small cell lung cancer? Travert, Camille Tomasini, Pascale Barlesi, Fabrice Transl Lung Cancer Res Editorial Commentary AME Publishing Company 2020-04 /pmc/articles/PMC7225151/ /pubmed/32420082 http://dx.doi.org/10.21037/tlcr.2020.02.08 Text en 2020 Translational Lung Cancer Research. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Editorial Commentary
Travert, Camille
Tomasini, Pascale
Barlesi, Fabrice
Chemotherapy and immune checkpoint inhibitor combination, a new standard in squamous non-small cell lung cancer?
title Chemotherapy and immune checkpoint inhibitor combination, a new standard in squamous non-small cell lung cancer?
title_full Chemotherapy and immune checkpoint inhibitor combination, a new standard in squamous non-small cell lung cancer?
title_fullStr Chemotherapy and immune checkpoint inhibitor combination, a new standard in squamous non-small cell lung cancer?
title_full_unstemmed Chemotherapy and immune checkpoint inhibitor combination, a new standard in squamous non-small cell lung cancer?
title_short Chemotherapy and immune checkpoint inhibitor combination, a new standard in squamous non-small cell lung cancer?
title_sort chemotherapy and immune checkpoint inhibitor combination, a new standard in squamous non-small cell lung cancer?
topic Editorial Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7225151/
https://www.ncbi.nlm.nih.gov/pubmed/32420082
http://dx.doi.org/10.21037/tlcr.2020.02.08
work_keys_str_mv AT travertcamille chemotherapyandimmunecheckpointinhibitorcombinationanewstandardinsquamousnonsmallcelllungcancer
AT tomasinipascale chemotherapyandimmunecheckpointinhibitorcombinationanewstandardinsquamousnonsmallcelllungcancer
AT barlesifabrice chemotherapyandimmunecheckpointinhibitorcombinationanewstandardinsquamousnonsmallcelllungcancer

Ejemplares similares